March 23, 2015

TB Alliance Announces Partnership with U.S. Fund for UNICEF to Increase Access to Impending New Child-Friendly TB Treatments

Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis
March 17, 2015

The Lancet: Results of Phase 2b Trial of Novel TB Regimen PaMZ Show Potential to Shorten, Improve TB Treatment

Phase 3 STAND Trial Launches to Advance PaMZ through Final Stage of Testing
February 17, 2015

TB Alliance Advances Next-generation TB Drug Candidate into Clinical Testing

TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
January 28, 2015

Phase 2a Published Results Show the Potential of a New TB Regimen with Novel Drugs Bedaquiline and Pretomanid (PA-824)

Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial
October 21, 2014

TB Alliance Launches Phase 2B Clinical Trial of a Novel TB Drug Regimen that Could Cut Treatment Time by Half or More for a Majority of TB Patients

NC-005 trial tests a novel regimen of bedaquiline (Sirturo), pretomanid (formerly known as PA-824), and pyrazinamide; results could pave the way for a three-month TB treatment